Stichting European Myeloma Network
Clinical trials sponsored by Stichting European Myeloma Network, explained in plain language.
-
CAR-T therapy challenges stem cell transplant as First-Line myeloma treatment
Disease control OngoingThis study compares two treatments for people newly diagnosed with multiple myeloma who are eligible for a stem cell transplant. One group gets standard drugs plus a stem cell transplant, while the other gets the same drugs followed by a single infusion of ciltacabtagene autoleuc…
Phase: PHASE3 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
New drug cocktail targets Hard-to-Treat myeloma spread
Disease control OngoingThis study tests a combination of four drugs (daratumumab, bortezomib, cyclophosphamide, and dexamethasone) in 41 people with multiple myeloma that has spread outside the bones, known as extramedullary disease. The goal is to see how well the treatment works and how safe it is. P…
Phase: PHASE2 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated Jun 05, 2026 12:07 UTC
-
New quadruple therapy shows promise in battling multiple myeloma
Disease control OngoingThis phase 3 study compares a four-drug combination (daratumumab, bortezomib, lenalidomide, and dexamethasone) against the standard three-drug regimen in 709 adults aged 18-70 with newly diagnosed multiple myeloma who are eligible for high-dose therapy. The goal is to see if addi…
Phase: PHASE3 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated Jun 03, 2026 12:02 UTC